CRDL Competitors & Alternatives
Compare Cardiol Therapeutics Inc. Class A Common Shares with similar stocks in the same industry
Biological Products, (No Diagnostic Substances)
CRDL
Main Stock$1.02
Tradestie Score
49
Market Cap
$89.59M
Analyst Upside
+667.9%
Top Competitors
170 stocks in Biological Products, (No Diagnostic Substances)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$339.41
|
$160.70B | 26.5 | 69 | Compare |
|
GILD
Gilead Sciences Inc
|
$144.98
|
$137.92B | 21.6 | 64 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$846.80
|
$46.96B | 36.2 | 57 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$106.42
|
$24.57B | - | 52 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$176.56
|
$22.61B | 16.0 | 57 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$138.52
|
$13.59B | 32.5 | 60 | Compare |
|
EXEL
Exelixis Inc
|
$42.31
|
$11.09B | 17.4 | 55 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$43.32
|
$10.74B | - | 59 | Compare |
|
QGEN
QIAGEN N.V.
|
$51.75
|
$10.04B | 27.5 | 62 | Compare |
|
TECH
Bio-Techne Corp.
|
$63.70
|
$9.33B | 130.8 | 56 | Compare |
More CRDL Analysis
Data updated: Feb 03, 2026 | Industry: Biological Products, (No Diagnostic Substances) (SIC 2836)
170 stocks in this industry